Stem Cell Therapies May Require Premarket Approval – Mondaq News Alerts (registration)
|
Stem Cell Therapies May Require Premarket Approval
Mondaq News Alerts (registration) Stem cell therapy may violate the good manufacturing and labeling provisions of Federal Food, Drug and Cosmetic Act (“FDCA”), if the biological characteristics of the cells employed are altered prior to administration to a subject. That seems to be the … |
